News

Cardiac Science has begun shipping its news Powerheart G3 Plus, a CPR-enhanced addition to the Powerheart automated ...

Home December 12, 2006
Home
News

MicroMed Cardiovascular, Inc. has received a CE Mark extension to continue marketing its DeBakey VAD system in Europe ...

Home December 12, 2006
Home
News

Volcano Corp., Stanford University, Cardialysis and the Cardiovascular Research Foundation in which Volcano will provide ...

Home December 12, 2006
Home
News

The FDA will convene a Medical Device Dispute Resolution Panel (MDDRP) on Dec. 15 to consider the first device to ...

Home December 12, 2006
Home
News

A strong grassroots effort among physicians played a key role in staving off a Medicare physician payment cut that would ...

Home December 11, 2006
Home
News

The FDA panel that convened for an intense, two-day review of drug-eluting stents last week heard key testimony from ...

Home December 11, 2006
Home
News

Taking anti-platelet medication longer than current recommendations may lower heart attack or death risks for patients ...

Home December 06, 2006
Home
News

Phase III of CoreValve’s international trial for its patented 18-French Revalving System is now one-third enrolled since ...

Home December 06, 2006
Home
News

FUJIFLM Medical Systems USA, Inc. (“Fuji”) and Problem Solving Concepts, Inc. (“ProSolv”) have announced a co-marketing ...

Home December 06, 2006
Home
News

Agfa HealthCare has signed a contract with the National Heart Centre (NHC) of Singapore, the national referral centre ...

Home December 06, 2006
Home
News

The FDA panel that is re-evaluating the safety of drug-eluting stents convenes Dec. 7 and 8 at the Hilton Washington DC ...

Home December 06, 2006
Home
News

The FDA will revisit a device tomorrow that it cleared for U.S. sale three years ago — drug-eluting stents will be the ...

Home December 05, 2006
Home
News

The American Heart Association has published a report demonstrating that adolescent boys have a significantly increased ...

Home December 05, 2006
Home
News

The FDA was notified on Dec. 2 that Pfizer will suspend a large, Phase 3 trial evaluating the investigational ...

Home December 05, 2006
Home
Case Study

One of the major dilemmas faced by clinicians in the Intensive Care Unit (ICU) is the determination of volume status and ...

Home December 04, 2006
Home
Subscribe Now